GOLPH3 and colonic neoplasm: Supporting this notion, (Yu et al., 2020), Yu et al. demonstrated that inhibition of GOLPH3 overcomes oxaliplatin resistance in colon cancer cells through downregulation of the PI3K/AKT/mTOR signaling pathway.